Urinary transforming growth factor-β1 and α1-microglobulin in children and adolescents with type 1 diabetes

被引:37
作者
Korpinen, E
Teppo, AM
Hukkanen, L
Åkerblom, HK
Grönhagen-Riska, C
Vaarala, O
机构
[1] Univ Helsinki, Hosp Children & Adolescents, FIN-00029 Helsinki, Finland
[2] Univ Helsinki, Dept Med, Div Nephrol, FIN-00029 Helsinki, Finland
[3] Natl Publ Hlth Inst, Dept Biochem, Helsinki, Finland
关键词
D O I
10.2337/diacare.23.5.664
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- Transforming growth factor (TGF)-beta 1 is an important mediator in the pathogenesis of diabetic nephropathy. Urinary TGF-beta 1 reflects TGF-beta 1 production in the kidney, and alpha 1-microglobulin tubular dysfunction. These 2 markers were studied in the early phases of type 1 diabetes. RESEARCH DESIGN AND METHODS - There were 113 type 1 diabetic children and adolescents (mean +/- SD: age 14.1 +/- 2.9 years, and diabetes duration 7.4 +/- 2.9 years, HbA(1c) 9.3 +/- 1.5%) and 39 healthy subjects (age 13.8 +/- 2.8 years) who participated in the study. Of the diabetic patients, 105 were normoalbuminuric (2-3 consecutive overnight urinary albumin excretion rates [AERs] <20 mu g/min) and 8 had microalbuminuria (at least 2 AERs 20-200 mu g/min). Overnight urinary TGF-beta 1 and alpha 1-microglobulin levels were measured and the results expressed as the ratio to urinary creatinine concentration. RESULTS - Data are medians (range). Diabetic patients had higher urinary TGF-beta 1 levels than those of control subjects: 0.9 ng/mg (0.05-122.3) vs. 0.3 ng/mg (0.05-2.2) creatinine, respectively (P = 0.003). Urinary TGF-beta 1 levels correlated with urinary glucose (r = 0.2, P = 0.03) and alpha 1-microglobulin (r = 0.2, P = 0.02) levels, but not with HbA(1c), AER, age, or duration of diabetes. In 43 patients with urinary TGF-beta 1 above the control levels, urinary TGF-beta 1 levels correlated with urinary glucose (r = 0.6, P ( 0.001) and alpha 1-microglobulin (r = 0.6, P < 0.001) levels. Diabetic patients had higher urinary alpha 1-microglobulin levels than those of control subjects: 4.8 mu g/mg (0.6-48.8) vs. 2.7 mu g/mg (0.8-11.6) creatinine, respectively (P < 0.001). alpha 1-Microglobulin levels correlated with AER (r = 0.2, P = 0.02), HbA(1c) (r = 0.3, P = 0.001), urinary glucose (r = 0.5, P < 0.001), and urinary TGF-beta 1 levels. CONCLUSIONS - An early rise in urinary TGF-P 1 levels was observed in young type 1 diabetic patients. Urinary TGF-beta 1 is associated with 2 interrelated tubular markers, alpha 1-microglobulin and urinary glucose.
引用
收藏
页码:664 / 668
页数:5
相关论文
共 29 条
[11]  
Han DC, 1999, J AM SOC NEPHROL, V10, P1891
[12]   Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells [J].
Hirakata, M ;
Kaname, S ;
Chung, UG ;
Joki, N ;
Hori, Y ;
Noda, M ;
Takuwa, Y ;
Okazaki, T ;
Fujita, T ;
Katoh, T ;
Kurokawa, K .
KIDNEY INTERNATIONAL, 1997, 51 (04) :1028-1036
[13]   Urinary transforming growth factor-β1 in membranous glomerulonephritis [J].
Honkanen, E ;
Teppo, AM ;
Tornroth, T ;
Groop, PH ;
Gronhagen-Riska, C .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (12) :2562-2568
[14]   HUMAN ALPHA-1-MICROGLOBULIN - ITS MEASUREMENT AND CLINICAL-SIGNIFICANCE [J].
ITOH, Y ;
KAWAI, T .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1990, 4 (05) :376-384
[15]   PERSISTING GLOMERULAR HYPERFILTRATION IN SHORT-TERM DIABETIC CHILDREN WITHOUT MICROALBUMINURIA [J].
LEVYMARCHAL, C ;
LABORDE, K ;
KINDERMANS, C ;
DECHAUX, M ;
CZERNICHOW, P .
ACTA PAEDIATRICA SCANDINAVICA, 1989, 78 (05) :712-716
[16]   TGF-β1 DNA polymorphisms, protein levels, and blood pressure [J].
Li, BG ;
Khanna, A ;
Sharma, V ;
Singh, T ;
Suthanthiran, M ;
August, P .
HYPERTENSION, 1999, 33 (01) :271-275
[17]   Urinary transforming growth factor-beta in patients with glomerular diseases [J].
Murakami, K ;
Takemura, T ;
Hino, S ;
Yoshioka, K .
PEDIATRIC NEPHROLOGY, 1997, 11 (03) :334-336
[18]   URINE TRANSFORMING GROWTH-FACTOR-BETA ACTIVITY IS RELATED TO THE DEGREE OF SCARRING IN CRESCENTIC NEPHRITIS IN THE RABBIT [J].
NOH, JW ;
WIGGINS, R ;
PHAN, SH .
NEPHRON, 1993, 63 (01) :73-78
[19]   Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism [J].
Pugliese, G ;
Pricci, F ;
Romeo, G ;
Pugliese, F ;
Mene, P ;
Giannini, S ;
Cresci, B ;
Galli, G ;
Rotella, CM ;
Vlassara, H ;
DiMario, U .
DIABETES, 1997, 46 (11) :1881-1887
[20]  
Riser BL, 1998, J AM SOC NEPHROL, V9, P827